title: The race to control pain: more participants, more targets.
authors.affiliation: Department of Pharmacology II, Grünenthal GmbH Research and Development, Zieglerstrasse 6, D-52078 Aachen, Germany. BorisChizh@aol.com
authors.forename: B A
authors.initials: BA
authors.lastname: Chizh
authors.forename: A H
authors.initials: AH
authors.lastname: Dickenson
authors.forename: S
authors.initials: S
authors.lastname: Wnendt
mesh_terms: D000085:Acetates / Q000627:therapeutic use; D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use; D000077206:Gabapentin; D006801:Humans; D018722:Nicotinic Agonists / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy*; D011955:Receptors, Drug / Q000187:drug effects; D015222:Sodium Channels / Q000187:drug effects; D005680:gamma-Aminobutyric Acid
chemical_list: D000085:Acetates; D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D018691:Excitatory Amino Acid Antagonists; D018722:Nicotinic Agonists; D011955:Receptors, Drug; D015222:Sodium Channels; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin